IGF1 and fatty liver disease: In the initially obese weight gain group, weight fluctuation associated with increased adiposity, followed by insulin resistance and hepatic steatosis, ultimately might lead to hepatic carcinogenesis by oxidative stress, lipotoxicity and stimulation of the IGF-1 axis by hyperinsulinemia47.